Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arik Schulze

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Angiogenesis|August 11, 2022
Persistent capillary rarefication in long COVID syndromeIrina Osiaevi, Arik Schulze, Georg Evers, et al.
European Journal of Haematology|July 12, 2018
<sup>90</sup> Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experienceEva U Spukti, Lars Henning Schmidt, Arik Schulze, et al.
Urologic Oncology|May 5, 2019
Noncaseating granulomatous diseases in germ cell cancer patients-A single-center experienceLars Henning Schmidt, Sebastian Huss, Christoph Schuelke, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Angiogenesis|August 11, 2022
Persistent capillary rarefication in long COVID syndromeIrina Osiaevi, Arik Schulze, Georg Evers, et al.
European Journal of Haematology|July 12, 2018
<sup>90</sup> Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experienceEva U Spukti, Lars Henning Schmidt, Arik Schulze, et al.
Urologic Oncology|May 5, 2019
Noncaseating granulomatous diseases in germ cell cancer patients-A single-center experienceLars Henning Schmidt, Sebastian Huss, Christoph Schuelke, et al.
Pageof 1